15 November 2022>: Clinical Research
Suppression of Tumorigenicity 2 Pro-Inflammatory Biomarker Linking Diabetes Mellitus and Periodontitis: A Pilot Study
Paladugu Devi Navya 1CDF , Gurumoorthy Kaarthikeyan 1CEF , J. Selva Raj 2BCDE , Ahmed Alamoudi 3AEF , Maha A. Bahammam 45CEF , Bassam Zidane 6BDE , Hammam Ahmed Bahammam 7BDF , Sarah Ahmed Bahammam 8CEF , Ali Abdel-Halim Abdel-Azim Hassan 9CDE , Mona Awad Kamil 10BDE , Shilpa Bhandi 1112BEF , A. Thirumal Raj 13CEF , Shankargouda Patil 1114ACE*DOI: 10.12659/MSM.938218
Med Sci Monit 2022; 28:e938218
Table 3 Comparison of suppression of tumorigenicity 2 (ST2) levels in gingival crevicular fluid (GCF) by sex and group.
Serial no. | Sex | Group | Mean | P value |
---|---|---|---|---|
1 | Male | 1 | 211.02 | 0.098 (NS) |
2 | 471.10 | |||
3 | 566.93 | |||
2 | Female | 1 | 315.52 | 0.078 (NS) |
2 | 423.38 | |||
3 | 550.80 | |||
Group 1, healthy; group 2, periodontitis; group 3, periodontitis with diabetes mellitus. NS – not significant. When the value is more than 0.05, there is no statistical difference between the sex and ST2 expression. |